MedPath

Investigating the effect of peppermint essential oil inhalation on improving lung function in patients with asthma

Phase 3
Recruiting
Conditions
Asthma disease, patients with grade 2 and 3 asthma.
Asthma
Registration Number
IRCT20231030059905N1
Lead Sponsor
Bojnourd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
48
Inclusion Criteria

Patients with level 2 or 3 asthma who have visited the clinic and have no acute respiratory problems

Exclusion Criteria

Measuring sensitivity to mint (one of the exit criteria): by taking a history of the symptoms of an allergic reaction to mint (itching, hives, shortness of breath).
Lack of personal satisfaction
Lack of bronchodilator-responsive asthma
High grades of asthma with clinical symptoms such as chronic and severe shortness of breath

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath